Happy Friday, friends! We are excited to end your week off on a positive note as we dive into the newest developments within cancer research.
As we continue through the month of October, let’s start with the newest developments of detecting secondary breast cancer. Researchers at Breast Cancer Now have developed an AI model that predicts the risk of secondary (metastatic) breast cancer returning after initial treatment. This model uses patient data, such as tumor size and lymph node involvement, to identify those at higher risk, allowing for earlier and more personalized treatments. The breakthrough could significantly improve long-term outcomes and help guide tailored patient care. The AI model represents a promising advance in the early detection and prevention of cancer recurrence.
Stay up to date with Breast Cancer Now and their continued research!
Immunotherapy is one of the leading breakthroughs in cancer research within the last year. Researchers at WEHI have developed a breakthrough CAR T cell therapy that not only kills glioma brain cancer cells but also strengthens the immune system to prevent recurrence. The two-in-one treatment targets the protein EphA3 on cancer cells, offering hope for a lasting solution against this aggressive, currently incurable cancer. This dual approach has the potential to revolutionize brain cancer treatment, improving survival rates and patient outcomes. Future clinical trials could further advance this promising immunotherapy.
Check out the full article here!
We’d love to hear any breakthroughs that you have found in the comments below! Thank you for being here! We hope you find small moments of joy this weekend!